Biologic drugs are the largest and fastest growing segment of the Pharmaceutical industry, with sales of €500bn and an annual growth of 8%.1 Their ability to target diseases with high specificity results in improved safety and effectiveness. However, this increases the cost of manufacturing significantly over their predecessors.
